Market LIVE
Published markets; coverage varies by country
Product profile · United States

ITOVEBI

 ·  Patent Litigation & Settlement History ↓

IngredientINAVOLISIB
Application typeNDA
Application219249
Product001
Dosage formTABLET
RouteORAL
Strength3MG
Approval date2024-10-10
Marketing statusPrescription
Status event—
ApplicantGENENTECH INC
Product source

Current GenericRadar decision

Year2036
SelectionDEEP_REVIEW
ReviewFINAL
Anchor typeTRUE_DS_PATENT
Anchor date2036-07-01
Patent anchor2036-07-01
Exclusivity anchor2029-10-10
Protection date2038-06-14
First Final ANDA—
Status event—

POST_ANCHOR_RIGHTS_EXIST; US:NDA:219249:001; exact Final ANDA not verified; not proof of generic absence

Patent estate

PatentEffective dateOfficial listingTRUE_DSDS gradeClaim classification / basisPTEPEDFamily
82421042030-09-27DS/DP —YNTRUE_DS
| B1C03P7 issued-claim review2026-10-15: TRUE_DS
———
82421042030-09-27ORANGE_BOOK —YNTRUE_DS
English description not available.
———
83439552030-09-27U U-4024NYU
| B1C03P7 issued-claim review2026-10-15: U
———
83439552030-09-27ORANGE_BOOK U-4024NYU
English description not available.
———
108510912036-07-01DS/DP —YNTRUE_DS
| B1C03P7 issued-claim review2026-10-15: TRUE_DS
———
108510912036-07-01ORANGE_BOOK —YNTRUE_DS
English description not available.
———
117607532036-07-01U U-4024NYU
| B1C03P7 issued-claim review2026-10-15: U
———
117607532036-07-01ORANGE_BOOK U-4024NYU
English description not available.
———
96503932036-07-01DS/DP/U U-4024YNTRUE_DS
| B1C03P7 issued-claim review2026-10-15: TRUE_DS
———
96503932036-07-01ORANGE_BOOK U-4024YNTRUE_DS
English description not available.
———
110281002038-04-26DS/DP —NNDP
| B1C03P7 issued-claim review2026-10-15: DP
———
110281002038-04-26ORANGE_BOOK —NNDP
English description not available.
———
124101892038-06-14U U-4024NNU
| B1C03P7 issued-claim review2026-10-15: U
———
124101892038-06-14ORANGE_BOOK U-4024NNU
English description not available.
———

Regulatory exclusivity

CodeStart dateEnd dateScopeEntire productAll indicationsFull coverage dateCombinationSource
NCE2024-10-102029-10-10English description not available.YY2029-10-10—Source
NCE2024-10-102029-10-10English description not available.YY2029-10-10
NCE
Full coverage date: 2029-10-10
Source

2026-10-10 · CURRENT_SOURCE_RECORDS_FOUND · Historical coverage: NOT_COMPLETE

Generic approval evidence

Application / productEventFinal dateTentative dateApplicantAuthorized genericExact mappingSource
No generic approval facts are linked to this product.

Market Entry Information

API filings, authorized generics and linked regulatory milestones.

API Master Files & Certifications 0 records

Ingredient-level registrations from linked public manufacturer portfolios. A filing does not establish supply to this finished product. DMFs are not FDA approvals.

APIHolder / manufacturerHolder countryFiling typeNumberStatusFiled dateAvailable for referenceSourceLast verified
No master-file or certification records are linked through public manufacturer portfolios.

Authorized Generics 0 records

Authorized generics are shown separately from independent ANDA approvals.

Application / productApplicantEvent / status First marketed Product mappingSourceLast verified
No authorized-generic records are linked to this product.

Tentative ANDA Approvals 0 records

Tentative approval is not final approval. Historical tentative approvals remain visible after a linked final approval.

Application / productApplicantEvent / status Tentative date Follow-up final approvalProduct mappingSourceLast verified
No tentative-approval records are linked to this product.

Paragraph IV Challenges 0 records

Paragraph IV challenges below are sourced from legal records separately from FDA approvals. An ANDA filing, lawsuit or settlement does not establish final approval or commercial launch.

Application / productApplicantEvent / status Certification event date Product mappingSourceLast verified
No structured Paragraph IV certification events are linked in the available approval evidence.

Final ANDA Approvals 0 records

Approval dates do not establish commercial launch. Product mapping is shown for each linked record.

Application / productApplicantEvent / status Final approval date Product mappingSourceLast verified
No final-approval records are linked to this product.
Decision evidence (9)
TypeDateRoleBasisSource
PATENT2030-09-27HISTORICAL_CONTEXTEnglish description not available.Source
PATENT2030-09-27HISTORICAL_CONTEXTEnglish description not available.Source
PATENT2036-07-01CANONICAL_ANCHOREnglish description not available.Source
PATENT2036-07-01CANONICAL_ANCHOREnglish description not available.Source
PATENT2036-07-01CANONICAL_ANCHOREnglish description not available.Source
PATENT2038-04-26FTO_TAILEnglish description not available.Source
PATENT2038-06-14FTO_TAILEnglish description not available.Source
REGULATORY_EXCLUSIVITY—REGULATORY_SCOPE_CONTEXTEnglish description not available.Source
REGULATORY_STATUS2036-07-01CANONICAL_DECISIONPOST_ANCHOR_RIGHTS_EXIST; US:NDA:219249:001; exact Final ANDA not verified; not proof of generic absenceSource
Independent legal-event information

Litigation & Settlement History

Settlement launch rights generally apply only to the named parties and product scope. These records do not change GenericRadar patent/exclusivity anchors or current decisions.

No litigation or settlement record currently linked to this product.